Athersys to Present at the Needham Virtual Healthcare Conference on April 14
Athersys, Inc. (NASDAQ: ATHX) announced that CFO Ivor Macleod will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on April 14, 2021, at 1:30 PM EDT. A live webcast can be accessed via the company’s website, and an archived replay will be available post-conference. The company invites institutional investors interested in virtual meetings with management to contact the conference coordinators. Athersys focuses on developing its proprietary MultiStem® cell therapy for various critical health issues, supported by strategic partnerships.
- None.
- None.
Athersys, Inc. (NASDAQ: ATHX) announced today that Mr. Ivor Macleod, Chief Financial Officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference. The presentation is scheduled for Wednesday, April 14, 2021 at 1:30 pm EDT. The company will also engage in virtual meetings with other institutional representatives at the conference.
A live webcast of the presentation can be accessed by visiting ‘Events & Presentations’ in the Investors Section on the Company’s website at www.athersys.com. An archived replay of the webcast will be available on the Company’s website after the conference for a limited time.
Institutional investors interested in arranging a virtual meeting with the Company’s management during the Needham conference should contact the conference coordinators at conferences@needhamco.com.
About Athersys
Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® (invimestrocel) cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210401005120/en/
FAQ
What is the schedule for Athersys' presentation at the 20th Annual Needham Virtual Healthcare Conference?
Where can I watch the Athersys presentation live?
How can institutional investors arrange a meeting with Athersys during the conference?
What is the focus of Athersys' MultiStem® cell therapy?
What is the ticker symbol for Athersys?
